Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.05
  • 52 Week Low: 0.72
  • Currency: UK Pounds
  • Shares Issued: 427.35m
  • Volume: 7,200
  • Market Cap: £3.21m

Regulatory News

Holding(s) in Company 30-Dec-2021 11:35 RNS
Grant of Options 08-Dec-2021 14:08 RNS
Half-year Report 07-Dec-2021 07:00 RNS
Notice of Results 23-Nov-2021 07:00 RNS
Publication of data on SFX-01 in glioblastoma 10-Nov-2021 07:00 RNS
Holding(s) in Company 19-Oct-2021 14:39 RNS
Holding(s) in Company 02-Sep-2021 14:32 RNS
Second Price Monitoring Extn 02-Sep-2021 14:06 RNS
Price Monitoring Extension 02-Sep-2021 14:00 RNS
Second Price Monitoring Extn 02-Sep-2021 11:05 RNS
Glioma Orphan Drug designation granted by FDA 02-Sep-2021 11:01 RNS
Price Monitoring Extension 02-Sep-2021 11:00 RNS
Holding(s) in Company 25-Aug-2021 16:42 RNS
Second Price Monitoring Extn 24-Aug-2021 16:41 RNS
Price Monitoring Extension 24-Aug-2021 16:36 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.05
52 Week Low 0.72
Volume 7,200
Shares Issued 427.35m
Market Cap £3.21m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
93.3% below the market average93.3% below the market average93.3% below the market average93.3% below the market average93.3% below the market average
70.37% below the sector average70.37% below the sector average70.37% below the sector average70.37% below the sector average70.37% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 09-May-2024

Time Volume / Share Price
12:31 7,200 @ 0.72p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page